Contact Information
Media Resources
High Resolution Image
Summary
Khalid Garman, M.D., M.Sc., Ph.D., is a staff scientist in the Dermatology Branch at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and an adjunct faculty member at Georgetown University, where he teaches pharmacology and pathophysiology. Combining clinical expertise with a strong background in pharmacology, Dr. Garman focuses on developing novel treatments for rare and aggressive skin cancers. His research spans high-throughput screening and preclinical and clinical drug development, with the goal of translating scientific discoveries into therapies that improve patient care.
Dr. Garman also holds leadership roles in the scientific community. He serves as chair of the Program Committee of the American Society for Pharmacology and Experimental Therapeutics (ASPET), which is responsible for developing the annual meeting’s scientific program. He also co-chairs the Trainee Committee of the Society for Investigative Dermatology (SID), supporting initiatives in trainee mentorship, engagement, and career development.
Research Statement
Dr. Garman's research aims to develop innovative single-agent and combination therapies for Merkel cell carcinoma, a rare and aggressive skin cancer. His work utilizes advanced high-throughput screening techniques, including small-molecule, functional genomic, and synergy matrix screening, to identify promising drug targets and explore their underlying mechanisms of action.
Additionally, his research emphasizes drug repurposing by investigating FDA-approved or clinically tested drugs, aiming to accelerate treatment options for patients who do not respond to existing therapies.
Scientific Publications
Education
Georgetown University
Ph.D. in Pharmacology (2018)
Georgetown University
M.Sc. in Pharmacology (2012)
University of Tripoli
M.D. (2007)
Experience
Postdoctoral Fellowship
NIAMS (2018-Present)
Adjunct Faculty
Georgetown University (2016-Present)